Summary. The effect of 6-diazo-6-oxo-L-norleucine (DON) 
Introduction
Two kinds of giant trophoblast cells can be distinguished in mice. On Day 4 of pregnancy, the mouse blastocyst hatches from the zona pellucida and attaches to the uterine epithelium (Gardner, 1975) . At this stage the abembryonic or mural trophoblast gives rise to the highly invasive primary giant trophoblast cells (Kirby & Cowell, 1968) and the polar trophoblast overlying the inner cell mass forms the ectoplacental cone. While polar trophoblast remains diploid and undifferentiated (Hernandez-Verdun, 1974) , the highly invasive secondary giant trophoblast cells which arise from its superficial regions erode into the maternal blood spaces and so become the only embryonic element in direct and continuous contact with the maternal tissues.
Primary giant trophoblast cells express maternal and paternal histocompatibility antigens detected by antibodies raised against spleen cells (Carter, 1976; Sellens, 1977) . Secondary giant cells of the ectoplacental cone do not express antigens in vitro (Carter, 1978) until they have been in culture for approximately 4 days (Billington, Jenkinson, Searle & Sellens, 1977; Carter, 1978) . H-2 antigens have been found on trophoblast cells in mice 14-18 days pregnant (Chatterjee-Hasrouni & Lala, 1979) , which suggests that mechanisms other than an absence of transplantation antigens operate to protect the feto-placental unit. For example, antigens may be absent from the layer of trophoblast in direct contact with the maternal circulation. Alternatively membrane-associated components may mask surface antigens.
Whole placenta contains a mass of amorphous material termed "fibrinoid" (Grosser, 1925) .
This layer is a negatively charged glycoprotein deposit with a high content of sialic and hyaluronic acid residues and has been suggested as a masking agent for surface antigens (Bulmer & Dickinson, 1961; Kirby, Billington, Bradbury & Goldstein, 1964; Bradbury, Billington & Kirby, 1965; Currie & Bagshawe, 1967 (Ghosh, Blumenthal, Davidson & Roseman, 1960; Buchanan, 1973) . DON has been shown to inhibit the formation of basement membrane and cell surface structures in a number of experimental systems: cartilage formation of mouse limb buds (Greene & Kochlar, 1975) ; odontoblast differentiation (Hurmerinta, Thesleff & Saxén, 1979) ; and kidney tubule induction (Ekblom, Lash, Lehtonen, Nordling & Saxén, 1979) . In addition, DON inhibits the synthesis of hyaluronic acid by 80% and other sulphated mucopolysaccharides by approximately 65% in palatal cell adhesion (Greene & Pratt, 1977 (Carter, 1978) . Briefly, blastocysts were flushed from the uteri of Day-4 pregnant mice with phosphate-buffered saline (PBS), pH 7-3. They were cultured in Snow C medium (Ansell & Snow, 1975) Fagraeus, Espmark & Jonsson (1965) and has been described in detail, with all specificity controls, elsewhere (Carter, 1978 [3] [4] [5] (90%), 3-0 (50-80%), 2-0 (25-50), 1-0 (10-25%), 0-5 (1-10%) (Carter, 1976) .
Permanent mounts of outgrowths were made by fixation for 1 h in 10% buffered formalin, followed by staining with haematoxylin and eosin and mounting with neutral glycerine jelly. When morulae were cultured in 0-5 or 1-0 pg DON/ml, they showed cavitation and expansion but did not hatch and eventually died. Blastocysts and expanded blastocysts also failed to hatch and eventually died. Table 1 shows the effects of different concentrations of DON on the antigenic expression of blastocyst outgrowths. (Carter, 1978) . After 2-4 days the cells of outgrowths in 1, 10 or 20 pg DON/ml lost their ability to adhere both to each other and to the coverslip, and after 4 days in culture were dead. At doses of 0-01 and 0-1 pg DON/ml, development was normal for the first 2 days but then varied numbers of cells in the outgrowth became rounded and were in suspension culture (PI. 1, Fig. 1 ). This lack of adhesion was overcome after incubation with DON (0-1, 1 and 20 pg/ml) plus glutamine (10 mM) for 2-4 days. However, secondary giant cells cultured in glucosamine (10 mM) + DON attached to the coverslip during the first 24 h but did not outgrow and were usually dead after 24 h in culture. Glucosamine at 5 mM was not toxic but did not overcome the inhibitory effect of DON.
The effect of DON on the antigenic expression of 'ao' outgrowths of ectoplacental cones is shown in Table 2 . The CBA CBA 'ao' outgrowths after incubation with anti-CBA serum in the MHA gave the expected score of zero and ' outgrowths a score of 4-0 (Carter, 1978 (Table 2) .
Glutamine (10 mM) was able to override the effect of 0-1 pg DON: antigen expression was not detectable on CBA or ScSn 'ao' outgrowths. It was not possible, however, to override the inhibition caused by 1 or 20 pg DON/ml with 10 mM-glutamine, and 20 mM-glutamine caused cell death.
Glucosamine (10 mM) caused cell death and 5 mM-glucosamine was unable to override the effect of DON. (6) Dead (8) (Table 3) . (Carter, 1978) . The present study has demonstrated that antigens are present on the secondary giant cells but are masked by glycosaminoglycans or glycoproteins, the synthesis of which is inhibited by 6-diazo-oxo-5-L-norleucine (DON). After incubation with DON for 24 h histocompatibility antigens can be detected on the secondary giant cells from CBA CBA and ScSn ScSn matings.
Morulae incubated with DON were able to cavitate but were unable to hatch. Early blastocysts were also unable to hatch although the blastocoele cavity increased in size. The late blastocyst was able to hatch but did not attach and outgrow. Therefore DON could not inhibit an already determined event but could prevent further development. These data are in agreement with those of Glass, Spindle & Pederson (1979) , although they were able to maintain cultures in much higher concentrations of DON.
The early development of secondary giant cells in vitro was not affected by low concentrations of DON, there was no difference in outgrowth size of numbers of "broken-out" cells (Carter, 1978 (Billington et ai, 1977; Carter, 1978) (Shreffler & David, 1975) and glycosylation is not a prerequisite for correct insertion and cleavage of membrane proteins (Garoff & Schwarz, 1978; Rothman, Katz & Lodish, 1978) . Secondly, it is possible that the masking substance has a rapid turnover and needs to be constantly synthesized whilst the antigen is not as frequently renewed. Although the precise identity of the antigens detected here is not known, preliminary experiments using recombinant strains have shown them to be linked to the H-2K region (J. Carter & C. Hetherington, unpublished observations) and it is possible that, as in the case of H-2 glycopeptides, antigenicity may be retained although the carbohydrate part of the glycoprotein has been inhibited by DON. DON competes with glutamine for the aminotransferase that converts fructose 6-phosphate to glucosamine 6-phosphate (Ghosh et ai, 1960; Ellis & Sommar, 1972; Trujillo & Gan, 1973) and lack of hexosamines prevents the elongation of carbohydrate components of glycosaminoglycans and glycoproteins (Greene & Pratt, 1977) . Concurrent incubation with glutamine or glucosamine would be expected to overcome the inhibitory effect of DON on the synthesis of the surface-masking substance. Glutamine did reverse the effect but glucosamine did not, possibly because it is toxic at the levels necessary to prevent DON inhibition. Others have also reported that glucosamine can be toxic (Kim & Conrad, 1974; Ekblom et ai, 1979; Hurmerinta et ai, 1979) . This reversal by glutamine makes it unlikely that DON is having its effect on antigen expression via some action outside transaminidation.
DON can interrupt pregnancy at mid-term and at the time of implantation (Thiersch, 1957; Jackson, Robson & Wander, 1959) in mice and rats. In mice injected on the 1st and 6th day of gestation, no placental remains were detected although a few intact placentae were found following the death of the fetuses when the drug was injected on Day 11. Although Thiersch (1957) and Jackson et ai (1959) 
